Related Experiment Videos
Bacterial toxins as tools for mucosal vaccination
Randall J Mrsny1, Ann L Daugherty, Marian L McKee
1Cardiff University, Center for Drug Delivery/Biology, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, UK CF10 3XF. mrsnyr@cf.ac.uk
Drug Discovery Today
|February 13, 2002
Summary
Bacterial toxins can induce immunity when applied to epithelial surfaces. A modified Pseudomonas aeruginosa exotoxin A (PE) shows promise as a vaccine by targeting immune cells across mucosal barriers.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Secreted bacterial toxins possess biological properties that can be utilized for inducing mucosal and systemic immunity.
- Application of these toxins at epithelial surfaces is a potential strategy for vaccine development.
Purpose of the Study:
- To review the properties and potential applications of bacterial toxins for inducing immunity.
- To focus specifically on Pseudomonas aeruginosa exotoxin A (PE) as a vaccination tool.
Main Methods:
- Review of existing studies on bacterial toxins and their immunogenic properties.
- Discussion of a modified non-toxic form of PE (ntPE) engineered for vaccine applications.
- Analysis of ntPE's ability to cross polarized epithelia and target antigen-presenting cells.
Main Results:
- ntPE can be engineered to incorporate antigenic epitopes, serving as a vaccine carrier.
- ntPE demonstrates the capacity to traverse the gastrointestinal, respiratory, and reproductive tract epithelia.
- ntPE selectively targets macrophages and dendritic cells, key players in immune response initiation.
Conclusions:
- Engineered non-toxic Pseudomonas aeruginosa exotoxin A (ntPE) is a promising vaccine candidate.
- ntPE's ability to breach mucosal barriers and target immune cells supports its potential for inducing broad immunity.